In a similar way, should the non-lysosomal GBA2 and sphingosine 1-phosphate be implicated, enzyme inhibitors of GBA2 and/or sphingosine kinases may be attractive strategies for the prevention of cancers in GD patients. This evidence concerns the gene GBA2 and cancer.